Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs JEHSX overlap: 97% of top holdings shared

Bottom line

How much do PRHSX and JEHSX overlap?

97% of their top holdings overlap by weight. 24 securities appear in both funds' top 25, making up 65.0% of PRHSX's assets and 66.6% of JEHSX's. They are largely the same portfolio — owning both adds little diversification.

Updated Nov 22, 2026

Overlap at a glance

PRHSXJEHSX
Weight overlap (top 25)97%
Shared holdings24
Weight in shared holdings65.0%66.6%
Total positions279173
Expense ratio0.83%1.04%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings PRHSX and JEHSX have in common

Holding% of PRHSX% of JEHSXOverlap
Eli Lilly & Co14.28%14.30%14.28%
Johnson & Johnson6.63%6.33%6.33%
Unitedhealth Group Inc5.99%5.95%5.95%
Abbvie Inc5.10%5.28%5.10%
Merck & Co. Inc.4.01%4.21%4.01%
Gilead Sciences Inc2.82%2.95%2.82%
Thermo Fisher Scientific Inc2.52%2.67%2.52%
Vertex Pharmaceuticals Inc2.28%2.38%2.28%
Bristol-myers Squibb Co2.11%2.22%2.11%
Abbott Laboratories1.89%2.00%1.89%
Intuitive Surgical Inc1.87%1.98%1.87%
Amgen Inc1.82%1.90%1.82%
Stryker Corp1.78%1.87%1.78%
Elevance Health Inc1.53%1.63%1.53%
Natera Inc1.44%1.49%1.44%
Danaher Corp1.43%1.51%1.43%
Guardant Health Inc1.23%1.28%1.23%
Cardinal Health Inc1.03%1.09%1.03%
Cvs Health Corp0.94%0.98%0.94%
Tenet Healthcare Corp0.94%0.99%0.94%
Kymera Therapeutics Inc0.89%0.93%0.89%
Protagonist Therapeutics Inc0.85%0.90%0.85%
Moderna Therapeutics Inc0.83%0.87%0.83%
Brightspring Health Services0.82%0.88%0.82%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Royalty Pharma Plc- Cl A — 0.97%

Only in JEHSX

  1. Royalty Pharma plc — 1.02%

Asset mix

Asset typePRHSXJEHSX
Stocks96.4%99.0%
Preferred stock3.0%—
Cash & short-term funds0.7%0.9%
Bonds0.2%0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryPRHSXJEHSX
US92.6%95.0%
GB1.7%0.8%
NL1.0%1.0%
IE0.8%0.9%
DK0.7%0.7%
BM0.7%—
CA0.6%—
JP0.5%0.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PRHSX and JEHSX overlap?
About 97% by weight. 24 securities appear in both funds' top 25 holdings; they make up 65.0% of PRHSX's assets and 66.6% of JEHSX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do PRHSX and JEHSX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Unitedhealth Group Inc, Abbvie Inc, Merck & Co. Inc..
Should I own both PRHSX and JEHSX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, PRHSX or JEHSX?
PRHSX is broader, with 279 positions versus 173 for JEHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.